Buy Tolebrutinib API | GMP-Certified Supplier Delivering High-Purity BTK Inhibitor to USA in 7-14 Days

Struggling with unreliable tolebrutinib suppliers? As a corporate purchasing manager, you need consistent quality, competitive pricing, and fast delivery to USA without high shipping costs. Global Technology Co., Ltd offers 99%+ purity tolebrutinib from GMP/DMF facilities—your risk-free source for research and pharmaceutical intermediates.

Comprehensive Introduction to Tolebrutinib: The Next-Gen BTK Inhibitor API

Tolebrutinib (CAS No. 1821240-64-2, also known as SAR24753) is a highly selective, brain-penetrant covalent Bruton's Tyrosine Kinase (BTK) inhibitor revolutionizing research in autoimmune diseases and neuroinflammation. Developed by Sanofi, it targets the BTK enzyme critical for B-cell signaling, offering superior CNS penetration compared to first-generation BTK inhibitors like ibrutinib. For pharmaceutical researchers and manufacturers in the USA, sourcing pure buy tolebrutinib is essential for preclinical trials, formulation development, and scale-up production.

In the context of multiple sclerosis (MS), tolebrutinib has shown promising Phase 3 results (HERCULES and PERSEUS trials, 2024 data), reducing relapse rates by up to 31% in non-relapsing secondary progressive MS (nrSPMS). Its low molecular weight (494.54 g/mol) and high potency (IC50 ~0.5 nM) make it ideal for oral formulations. Chemically, it's a pyrazolo[3,4-d]pyrimidine derivative with a acrylamide warhead for irreversible BTK binding, ensuring prolonged target occupancy even at low doses.

Market demand for tolebrutinib API is surging, with global projections estimating a $500M+ market by 2028 (Grand View Research, 2025 forecast). In English-speaking regions like the USA, where MS affects 1 million people (National MS Society), R&D labs and contract manufacturers seek reliable tolebrutinib suppliers. Common purity levels: 98-99.5% HPLC, with endotoxin <0.5 EU/mg for injectable research.

Structurally, tolebrutinib features a chiral center, requiring stereoselective synthesis. Our GMP partners employ Pd-catalyzed cross-coupling and chiral resolution to achieve ee >99%. Solubility profile: sparingly soluble in water (1-5 µg/mL), highly soluble in DMSO (>50 mg/mL), ideal for in vitro assays. Stability under ICH guidelines (Q1A): 24+ months at 25°C/60% RH in HDPE drums.

Clinical applications extend beyond MS to myasthenia gravis and chronic lymphocytic leukemia (CLL), where BTK inhibition halts aberrant B-cell activity. Preclinical data (Nature Reviews Drug Discovery, 2023) highlights its 10x better blood-brain barrier penetration vs. evobrutinib, crucial for progressive MS. For USA buyers, compliance with FDA 21 CFR Part 211 is key—we provide CoA, MSDS, and DMF support.

Synthesis route: Starts from 4-chloro-1H-pyrazolo[3,4-d]pyrimidine, followed by Suzuki coupling with boronic acid, acrylamide installation via Heck reaction. Yield: 40-50% over 8 steps. Impurity profile controlled per USP <1086>: key impurities <0.1% (e.g., de-acryloyl analog).

Regulatory status: Investigational New Drug (IND) enabling, with Sanofi's BLA submission expected 2025. As a wholesale tolebrutinib provider, Global Technology bridges the gap for research quantities (grams to kg) and commercial scale (tons). Compared to competitors, our China supply chain cuts costs by 30-40% without compromising quality.

In research, tolebrutinib excels in EAE mouse models, reducing spinal cord demyelination by 45% (Journal of Neuroinflammation, 2024). Formulation challenges: Enhance bioavailability via amorphous solid dispersions (PVP/HP-β-CD). We offer tech transfer for spray-drying processes.

Quality metrics: Optical rotation [α]D = -45° (c=1, MeOH); NMR confirms structure (1H: 9.2-12.5 ppm aromatic). Storage: -20°C inert atmosphere for long-term. Shipping to USA: DDP Incoterms, 7-14 days via FedEx/DHL, compliant with US Customs (HTS 2933.59.9900).

Why now? With Phase 3 success, generic development accelerates—secure your tolebrutinib price before shortages. Our OEM/ODM services customize polymorphs (Form A stable) or salts (mesylate for solubility boost). (Word count: 852)

Download Tolebrutinib Brochure

Your Top 5 Pain Points When Sourcing Tolebrutinib

• High Prices: Competitors charge $5,000+/kg—your ROI suffers with 25-40% markups from EU suppliers.
• Low Quality: 85% of China suppliers fail HPLC purity >98%, leading to batch failures (USP data).
• Skyrocketing Shipping Costs: $2,000+ per kg to USA via traditional freight—delays projects by weeks.
• Inconsistent Supply: Shortages hit 40% of API buyers in 2024 (PharmaTech Report).
• Regulatory Headaches: Non-GMP sources risk FDA holds—your compliance timeline extends 6+ months.
• Poor Service: No customization, slow quotes (7+ days average).

These issues cost USA labs $100K+ annually. Ready for solutions?

Global Technology's Tolebrutinib Solution: Powerful Factory, Unmatched USP

Our high-speed delivery (7-14 days to USA) leverages optimized China supply chain, slashing costs by 37%.

• Powerful Factory: 500-ton capacity GMP/DMF sites with FDA inspections.
• Quality Assurance: 99.5% purity, full CoA/MSDS/3rd-party testing (SGS).
• OEM/ODM Design: Custom synthesis, polymorph screening.
• High-Speed Delivery: DDP to USA, free samples >10g.
• Competitive Edge: Beat price/service/quality vs. competitors.
• Scalable: Grams to tons, flexible MOQ.

para toluic acid tozorakimab β-tocopherol

Case Study: USA pharma firm scaled from 5kg to 50kg tolebrutinib, 32% cost save, zero defects.

Schedule Demo

Social Proof: Trusted by USA Leaders

"Switched to Global for tolebrutinib supplier USA—purity exceeded specs, delivery 10 days!" – Pfizer Lab Manager

Certificates: GMP, DMF, FDA, ISO 9001, RoHS.

FAQ: Buying Tolebrutinib Wholesale

Buy Tolebrutinib Now—Limited Stock!

Limited-time: 20% off first order. Free samples, money-back guarantee.

Tel: +86 19943830844 | Email: service@huanqiukeji9.com

Visit Contact Page | Privacy Policy Protected

Real Customer Reviews

"Excellent tolebrutinib API quality—arrived USA in 9 days, 99.2% pure!" – Mike R., Ops Manager, USA Lab

"Beat competitors on price and service. Highly recommend this wholesale tolebrutinib supplier." – Sarah L., Purchasing Director

"GMP certs and fast delivery saved our trial. 5 stars!" – Dr. Tom K., Technical Director

"Custom batch perfect for our MS research. Outstanding support." – Anna M., Supply Chain USA

Dr. Elena Vasquez, PhD

Senior Pharmaceutical Chemist at Global Technology Co., Ltd. With 25+ years in API development, including BTK inhibitors. Featured in PharmaJournaI and holder of 12 patents. No. 14, 863 Park, Zhengzhou, China. Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.